Antonella Cingolani
Università Cattolica del Sacro Cuore
H-index: 52
Europe-Italy
Top articles of Antonella Cingolani
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort | Liver International | Antonella d’Arminio Monforte Alessandro Tavelli Romina Salpini Lorenzo Piermatteo Stefano D'Anna | 2024/2 |
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis–results from the ICONA cohort in Italy, 2009-2022 | International Journal of Infectious Diseases | Annalisa Mondi Alessandro Cozzi-Lepri Alessandro Tavelli Antonella Cingolani Andrea Giacomelli | 2024/5/1 |
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era | International Journal of Infectious Diseases | Alessandra Vergori Alessandro Cozzi Lepri Marta Chiuchiarelli Valentina Mazzotta Elisabetta Metafuni | 2024/4/12 |
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the … | Journal of Antimicrobial Chemotherapy | Antonella d’Arminio Monforte Alessandro Tavelli Antonio Di Biagio Loredana Sarmati Giulia C Marchetti | 2024/4/6 |
Real world use of Tixagevimab/Cilgavimab pre-exposure prophylaxis of COVID-19 in immunocompromised individuals: data from the OCTOPUS study. | Alessandra Vergori Giulia Matusali Eleonora Cimini Licia Bordi Paola Borrelli | 2024/3/9 | |
Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin | Diagnostic Microbiology and Infectious Disease | Eugenia Magrini Emanuele Rando Paola Del Giacomo Elena Matteini Gabriele Maria Leanza | 2024/2/2 |
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 | EClinicalMedicine | Jon Salmanton-García Francesco Marchesi Francesca Farina Barbora Weinbergerová Federico Itri | 2024/5/1 |
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial | European Journal of Internal Medicine | Carlo Perricone Mirko Scarsi Antonio Brucato Paola Pisano Erika Pigatto | 2023/1/1 |
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda | Giovanni Guaraldi Paolo Bonfanti Antonio Di Biagio Andrea Gori Jovana Milić | 2023/4/14 | |
Pillars of long-term antiretroviral therapy success | Lucia Taramasso Massimo Andreoni Andrea Antinori Alessandra Bandera Paolo Bonfanti | 2023/8/28 | |
Implementing an electronic patient-reported outcomes (ePROs) system for PLWH: Experience of Icona cohort | Applied Clinical Informatics | Sabrin Rizk Vera C Kaelin Julia Gabrielle C Sim Natalie J Murphy Beth M McManus | 2023/1 |
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry | Journal of Hematology & Oncology | Francesco Marchesi Jon Salmanton-García Caterina Buquicchio Federico Itri Caroline Besson | 2023/4/1 |
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial | Cell Reports Medicine | Stefania Capone Francesco M Fusco Stefano Milleri Silvio Borrè Sergio Carbonara | 2023/6/20 |
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic | Bone Marrow Transplantation | Eugenio Galli Alice Di Rocco Ilaria Pansini Federico Frondizi Martina Di Palma | 2023/12 |
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: A phase 3, randomized, open-labeled, multi-center study (ESCAPE study) | EClinicalMedicine | Ilaria Mastrorosa Roberta Gagliardini Francesco Vladimiro Segala Annalisa Mondi Patrizia Lorenzini | 2023/3/1 |
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 | Journal of Personalized Medicine | Maria Camilla Cipriani Cristina Pais Vezio Savoia Cinzia Falsiroli Andrea Bellieni | 2023/6/9 |
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network | International Journal of Infectious Diseases | Andrea Giacomelli Roberta Gagliardini Alessandro Tavelli Sara De Benedittis Valentina Mazzotta | 2023/11/1 |
Limited BA. 5 neutralization by pre-exposure prophylaxis with tixagevimab/cilgavimab in CAR-T treated people | Alessandra Vergori Giulia Matusali Elisabetta Metafuni Licia Bordi Paola Borrelli | 2023/2/23 | |
Awareness and perception of accuracy of the Undetectable= Untransmittable message (U= U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people … | AIDS care | A Cingolani A Tavelli GV Calvino F Maggiolo E Girardi | 2023/6/3 |
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort | Liver International | Antonella d’Arminio Monforte Alessandro Tavelli Roberto Rossotti Roberta Gagliardini Annalisa Saracino | 2023/10 |
